NCT02040883 Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia Status UNKNOWN Phase PHASE4
NCT02037581 Integrated Care Including Assertive Community Treatment in Early Psychosis Status COMPLETED Phase NA
NCT02037074 Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics Status COMPLETED Phase PHASE1
NCT02035202 Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness Status COMPLETED Phase NA
NCT02034474 Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia Status COMPLETED Phase PHASE4
NCT02034253 Glutamate, Brain Connectivity and Duration of Untreated Psychosis Status COMPLETED Phase N/A
NCT02021201 The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia Status TERMINATED Phase PHASE4
NCT02019329 A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone Status COMPLETED Phase PHASE1
NCT02013622 Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia Status COMPLETED Phase PHASE3
NCT02013232 Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia Status UNKNOWN Phase NA
NCT02011750 Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia Status COMPLETED Phase PHASE4
NCT02008773 A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia Status COMPLETED Phase PHASE2
NCT02007928 Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic Status COMPLETED Phase NA
NCT02006628 A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder Status COMPLETED Phase PHASE2